Telehealth Rapid Intervention for Externalizing Behaviors in ASD
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Sep 15, 2021
Trial Information
Current as of November 13, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study tests a short, telehealth version of Parent-Child Interaction Therapy (called Tele-PCIT) for young children who have autism and challenging behaviors. Children aged 2 years to under 7 years (up to 83 months) with an ASD diagnosis and noticeable disruptive behavior will be randomly assigned to either Tele-PCIT (10 sessions over about 12 weeks, delivered by video with the therapist coaching the parent) or to Treatment as Usual (typical community care). Researchers will assess changes in the child’s behavior and in how the parent and child interact before treatment, right after treatment (about 12 weeks), and again around 24 weeks. They will use several well-known scales and observations to measure behavior, compliance, parenting practices, and parent stress.
To be eligible, a child must have ASD confirmed by standard tests, show elevated disruptive behaviors, be 2 to 6 years 11 months old, and have receptive language around the level of 24 months or higher. Families should come from a low-income background (Medicaid) and there should be no severe self-injury or unstable changes in any psychotropic medications. The study is led by the Medical University of South Carolina in Charleston, funded in part by HRSA, and is currently enrolling by invitation. If eligible, families participate for about 12 weeks, may receive a tablet or headset for telehealth, and complete surveys and some observational assessments; the Tele-PCIT option aims to be convenient by delivering therapy at home while helping researchers learn about treatment satisfaction and any barriers to telehealth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Be between 2:0 -6:11 years old
- • 2. Have elevated levels of disruptive behavior problems as defined by the Eyberg Child Behavior Inventory
- • 3. Have a diagnosis of ASD based on a positive Autism Diagnostic Observation Schedule (ADOS-2), a semi-structured parent interview, record review, and an ASD DSM-5 criteria checklist.
- • 4. Have a receptive language age equivalent of at least 24 months as defined by the Peabody Picture Vocabulary Test
- • 5. Are of low SES background defined by having primary Medicaid
- Exclusion Criteria:
- • 1. Presence of severe self-injurious behavior
- • 2. Children who are receiving psychotropic medication and are not stable on their current medication regimen. Children receiving psychotropic medications who are on a stable regimen for one month will not be excluded.
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials